2025-08-20
APOE: the gene that makes you age faster… or slower?
Geriatrics
By Ana Espino | Published on August 20, 2025 | 2 min read
#APOE #Aging #GeneticFactor
Normal aging is accompanied by progressive cognitive and biological changes, distinct from the alterations observed in neurodegenerative diseases such as Alzheimer’s disease. However, the molecular mechanisms governing this process remain incompletely understood. Current approaches struggle to explain why some individuals preserve cognitive functions, while others experience marked decline despite no diagnosed pathology.
The major challenge is therefore to identify genetic factors that influence the trajectory of brain aging independently of disease processes. Among these, the APOE gene cluster—including the ε4 allele (already recognized as an Alzheimer’s risk factor), but also neighboring genes—has drawn increasing attention. The aim of this review is to analyze the role of APOE and its genomic cluster in normal aging, highlighting their potential effects on cognition, lipid metabolism, inflammation, and neuronal plasticity.
This review draws on genetic, transcriptomic, and clinical studies conducted in elderly individuals without a dementia diagnosis. Genetic analyses evaluated the impact of different APOE cluster alleles on the cognitive and biological trajectory of aging. Transcriptomic approaches examined the expression of genes linked to lipid metabolism and inflammation. Clinical cohorts, sometimes combined with brain imaging data, made it possible to relate APOE status to age-related cognitive and structural changes.
Findings show that the APOE gene significantly influences brain aging, with variable effects depending on isoforms. The ε4 allele, well known as a risk factor for Alzheimer’s, is associated with increased age-related cognitive decline even in the absence of neurodegenerative disease. Conversely, the ε2 allele appears protective, slowing certain aspects of cognitive decline. Analyses also indicate that the APOE cluster modulates brain lipid metabolism, inflammatory response, and synaptic function—all processes tied to neuronal resilience during aging. Brain imaging studies confirm that ε4 carriers display early structural and functional alterations, whereas ε2 carriers preserve better brain integrity.
Normal aging is a heterogeneous process, shaped by complex interactions among environmental, biological, and genetic factors. The APOE cluster now emerges as a strong candidate for explaining variability in individual cognitive trajectories, beyond its well-established role in Alzheimer’s disease. The aim of this review was to clarify its specific impact on normal brain aging. Results show that APOE—particularly its ε2 and ε4 variants—acts as a key modulator of cognitive and biological aging, steering trajectories toward either protection or vulnerability.
Large-scale longitudinal studies, combined with the development of specific biomarkers and the exploration of interactions with environment and lifestyle, will be needed to confirm these findings. Such advances could open the way toward precision medicine in aging, aimed at preserving cognitive health for longer.
About the author – Ana Espino
As a scientific writer, Ana is passionate about bridging the gap between research and real-world impact. With expertise in immunology, virology, oncology, and clinical studies, she makes complex science clear and accessible. Her mission: to accelerate knowledge sharing and empower evidence-based decisions through impactful communication.
#APOE #Aging #GeneticFactor
Normal aging is accompanied by progressive cognitive and biological changes, distinct from the alterations observed in neurodegenerative diseases such as Alzheimer’s disease. However, the molecular mechanisms governing this process remain incompletely understood. Current approaches struggle to explain why some individuals preserve cognitive functions, while others experience marked decline despite no diagnosed pathology.
The major challenge is therefore to identify genetic factors that influence the trajectory of brain aging independently of disease processes. Among these, the APOE gene cluster—including the ε4 allele (already recognized as an Alzheimer’s risk factor), but also neighboring genes—has drawn increasing attention. The aim of this review is to analyze the role of APOE and its genomic cluster in normal aging, highlighting their potential effects on cognition, lipid metabolism, inflammation, and neuronal plasticity.
Aging with APOE: guardian angel or achilles’ heel?
This review draws on genetic, transcriptomic, and clinical studies conducted in elderly individuals without a dementia diagnosis. Genetic analyses evaluated the impact of different APOE cluster alleles on the cognitive and biological trajectory of aging. Transcriptomic approaches examined the expression of genes linked to lipid metabolism and inflammation. Clinical cohorts, sometimes combined with brain imaging data, made it possible to relate APOE status to age-related cognitive and structural changes.
Findings show that the APOE gene significantly influences brain aging, with variable effects depending on isoforms. The ε4 allele, well known as a risk factor for Alzheimer’s, is associated with increased age-related cognitive decline even in the absence of neurodegenerative disease. Conversely, the ε2 allele appears protective, slowing certain aspects of cognitive decline. Analyses also indicate that the APOE cluster modulates brain lipid metabolism, inflammatory response, and synaptic function—all processes tied to neuronal resilience during aging. Brain imaging studies confirm that ε4 carriers display early structural and functional alterations, whereas ε2 carriers preserve better brain integrity.
APOE: the key to a brain that stays young?
Normal aging is a heterogeneous process, shaped by complex interactions among environmental, biological, and genetic factors. The APOE cluster now emerges as a strong candidate for explaining variability in individual cognitive trajectories, beyond its well-established role in Alzheimer’s disease. The aim of this review was to clarify its specific impact on normal brain aging. Results show that APOE—particularly its ε2 and ε4 variants—acts as a key modulator of cognitive and biological aging, steering trajectories toward either protection or vulnerability.
Large-scale longitudinal studies, combined with the development of specific biomarkers and the exploration of interactions with environment and lifestyle, will be needed to confirm these findings. Such advances could open the way toward precision medicine in aging, aimed at preserving cognitive health for longer.
Read next: Neurodegeneration: the shadow of a deficiency?
About the author – Ana Espino
PhD in Immunology, specialized in Virology
Last press reviews
Haemophilus influenzae: mere passenger or true driver of bronchiectasis?
By Ana Espino | Published on August 19, 2025 | 2 min read
Schizophrenia: when sugar plays with the brain
By Ana Espino | Published on August 14, 2025 | 2 min read